IONIS PHARMACEUTICALS INCIONS

Market cap

$12.9B

P/E ratio

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	70	65	124	160	143	129	85	130	279	683	398	869	276	399	242
Marketable securities, current	805	278	250	497	586	650	581	893	1,805	1,816	1,495	2,492	1,710	1,932	2,056
Total cash & short-term investments	875	344	374	657	729	779	665	1,023	2,084	2,500	1,892	3,361	1,987	2,331	2,298
Inventories	-	-	-	-	-	-	-	-	9	18	22	25	22	28	13
Total current assets	483	360	423	736	837	837	798	1,168	2,208	2,721	2,131	2,345	2,203	2,642	2,620
Property, plant and equipment, net	36	97	91	86	89	90	93	122	132	154	181	178	74	71	94
Total non-current assets	67	125	122	112	119	119	115	154	460	513	259	267	331	348	383
Total assets	550	485	546	847	956	956	912	1,322	2,668	3,233	2,390	2,612	2,534	2,990	3,004
Accounts payable	7	8	10	11	18	28	21	25	29	16	17	12	18	26	43
Total current liabilities	106	76	74	98	115	149	134	225	280	273	583	241	312	448	309
Total non-current liabilities	200	237	289	371	583	606	679	679	1,200	1,276	963	1,599	1,649	2,155	2,106
Total liabilities	306	313	363	469	698	755	813	903	1,481	1,549	1,546	1,840	1,961	2,603	2,415
Common stock and paid-in capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained earnings	-757	-841	-907	-968	-1,007	-1,095	-1,181	-1,187	-967	-708	-1,249	-1,160	-1,430	-1,796	-2,250
Stockholders' equity	245	171	183	378	258	201	100	419	1,187	1,685	843	772	573	387	588